论文信息 - Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy - 字舞流文

Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy

Franco Blanchini | Patrizio Colaneri | Giuseppe De Nicolao | Paolo Bolzern | Alessandro Di Filippo | Marta Colaneri | Raffaele Bruno | Giulia Giordano | Paolo Sacchi | G. Nicolao | P. Colaneri | P. Bolzern | F. Blanchini | R. Bruno | G. Giordano | M. Colaneri | P. Sacchi | A. Filippo | A. Di Filippo | Giuseppe De Nicolao

[1] B. Autran,et al. SARS-CoV-2 variants and ending the COVID-19 pandemic , 2021, The Lancet.

[2] T. Burki. Understanding variants of SARS-CoV-2 , 2021, The Lancet.

[3] M. Perc,et al. An action plan for pan-European defence against new SARS-CoV-2 variants , 2021, The Lancet.

[4] E. Callaway. Could new COVID variants undermine vaccines? Labs scramble to find out , 2021, Nature.

[5] Emil N. Iftekhar,et al. Calling for pan-European commitment for rapid and sustained reduction in SARS-CoV-2 infections , 2020, The Lancet.

[6] E. Crisostomi,et al. Post-lockdown abatement of COVID-19 by fast periodic switching , 2020, PLoS Comput. Biol..

[7] D. Swerdlow,et al. The importance of continued non-pharmaceutical interventions during the upcoming SARS-COV-2 vaccination campaign , 2020, medRxiv.

[8] T. Hotz,et al. How to coordinate vaccination and social distancing to mitigate SARS-CoV-2 outbreaks , 2020, medRxiv.

[9] P. Dormitzer,et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine , 2020, The New England journal of medicine.

[10] J. Bloom,et al. Prospective mapping of viral mutations that escape antibodies used to treat COVID-19 , 2020, bioRxiv.

[11] L. Saha,et al. COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies , 2020, European Journal of Pharmacology.

[12] M. Rypdal,et al. Intervention Fatigue is the Primary Cause of Strong Secondary Waves in the COVID-19 Pandemic , 2020, International journal of environmental research and public health.

[13] C. Silvestri,et al. Treatment for COVID-19: An overview , 2020, European Journal of Pharmacology.

[14] D. Larremore,et al. Model-informed COVID-19 vaccine prioritization strategies by age and serostatus , 2020, Science.

[15] K. Abbasi. Behavioural fatigue: a flawed idea central to a flawed pandemic response , 2020, BMJ.

[16] R. Williams,et al. The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation , 2020, AAPS PharmSciTech.

[17] P. Colaneri,et al. Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy , 2020, Nature Medicine.

[18] Marco D'Arienzo,et al. Assessment of the SARS-CoV-2 basic reproduction number, R0, based on the early phase of COVID-19 outbreak in Italy , 2020, Biosafety and Health.

[19] Yonatan H. Grad,et al. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period , 2020, Science.

[20] E. Holmes,et al. A new coronavirus associated with human respiratory disease in China , 2020, Nature.

[21] P. Cochat,et al. Et al , 2008, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.